Inhaled budesonide in ventilator-dependent preterm infants: a randomized, double-blind pilot study

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Clinical Pharmacology

Background:

• Preterm infants often require mechanical ventilation due to underdeveloped lungs.
• Inflammation plays a key role in ventilator-induced lung injury in neonates.
• Early therapeutic interventions are crucial for improving outcomes in vulnerable preterm infants.

Purpose of the Study:

• To assess the short-term effectiveness of early inhaled budesonide therapy.
• To determine if budesonide reduces the duration of mechanical ventilation in preterm infants.
• To evaluate the impact of budesonide on inflammatory markers and oxygen requirements.

Main Methods:

• Randomized, double-blind pilot study design.
• Inclusion of ventilator-dependent preterm infants.
• Administration of early inhalation therapy with budesonide.
• Measurement of ventilation duration, oxygen needs, and inflammatory mediators.

Main Results:

• No significant difference in the duration of artificial ventilation between budesonide and placebo groups.
• Similar ventilatory parameters and supplemental oxygen requirements at day 14 of life.
• No reduction in inflammatory mediators observed in the budesonide group.
• No adverse side effects reported in either treatment arm.

Conclusions:

• Early aerosolized budesonide did not demonstrate significant short-term pulmonary benefits in ventilator-dependent preterm infants.
• The study suggests budesonide is not effective for reducing ventilation duration or inflammation in this population.
• Further research may be needed to explore alternative therapeutic strategies for neonatal respiratory support.